ASTEX

Serial Number 85446581
606

Registration Progress

Application Filed
Oct 13, 2011
Under Examination
Nov 20, 2012
Approved for Publication
Sep 25, 2012
Published for Opposition
Sep 25, 2012
Registered

Trademark Image

ASTEX

Basic Information

Serial Number
85446581
Filing Date
October 13, 2011
Published for Opposition
September 25, 2012
Abandonment Date
December 21, 2015
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 21, 2015
Classes
001 005 044

Rights Holder

Astex Pharmaceuticals, Inc.

03
Address
4420 Rosewood Drive, Suite 200
Pleasanton, CA 94588

Ownership History

Astex Pharmaceuticals, Inc.

Original Applicant
03
Dublin, CA

Astex Pharmaceuticals, Inc.

Owner at Publication
03
Pleasanton, CA

Legal Representation

Attorney
Nancy DiConza

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

45 events
Date Code Type Description Documents
Dec 21, 2015 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 21, 2015 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
May 27, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 26, 2015 EX5G S SOU EXTENSION 5 GRANTED Loading...
Apr 30, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 30, 2015 EXT5 S SOU EXTENSION 5 FILED Loading...
Mar 11, 2015 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 11, 2015 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Nov 14, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 13, 2014 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 31, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 31, 2014 EXT4 S SOU EXTENSION 4 FILED Loading...
May 14, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 13, 2014 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 8, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 8, 2014 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 8, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 7, 2013 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 24, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 24, 2013 EXT2 S SOU EXTENSION 2 FILED Loading...
May 31, 2013 NOAC E CORRECTED NOA E-MAILED Loading...
May 31, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 30, 2013 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
May 30, 2013 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 23, 2013 MAIL I PAPER RECEIVED Loading...
May 21, 2013 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 17, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 17, 2013 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
May 17, 2013 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 20, 2012 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 25, 2012 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 25, 2012 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 5, 2012 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 20, 2012 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Aug 16, 2012 ALIE A ASSIGNED TO LIE Loading...
Aug 9, 2012 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 4, 2012 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 3, 2012 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 3, 2012 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 7, 2012 CPRA R PRIORITY ACTION WRITTEN Loading...
Feb 7, 2012 GPRA F PRIORITY ACTION E-MAILED Loading...
Feb 7, 2012 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
Feb 1, 2012 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 19, 2011 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 17, 2011 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Chemicals, chemical compounds and chemical preparations for non-medical purposes, namely, those for use in the field of biotechnology; chemicals, chemical compounds and chemical preparations for medical research purposes, namely, those for use in the field of drug discovery and the manufacture or development of pharmaceuticals; diagnostic preparations and/or reagents for clinical or medical laboratory use
First Use Anywhere: 0
First Use in Commerce: 0
Class 005
Pharmaceuticals, namely, pharmaceutical preparations for the diagnosis or treatment of diseases and disorders, namely, oncological, neurological, dermatological, hematological, bone, respiratory, central nervous system, endrocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, stomach and digestive disorders, muscular and/or rheumatic disorders, immune system disorders, allergic reactions, metabolic disorders, ocular disorders and pain; pharmaceuticals, namely, anti-inflammatory agents and anti-infectives
First Use Anywhere: 0
First Use in Commerce: 0
Class 044
Providing health care information via telephone
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of a stylized letter "A" above the stylized word "ASTEX". The gray tones are to indicate shading.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
001 005 044